ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993

PCI Files Application For Research Base COP

September 9, 1994